Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Taiwan operations

9 Aug 2017 07:00

RNS Number : 4483N
Haydale Graphene Industries PLC
09 August 2017
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

For immediate release

9 August 2017

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Launch of Taiwan operations

 

Haydale (AIM:HAYD), the global advanced materials group, is pleased to announce the launch of its Taiwan operations, Haydale Technologies (Taiwan) Co., Ltd., ('HTW'), which will operate as a dedicated producer and sales outlet of graphene-based conductive inks and pastes, including other functional and specialty inks and pastes.

 

Located in Kaohsiung, Southern Taiwan, HTW has largely completed the set-up of its own dedicated ink production facility to meet its anticipated demand. Haydale has been working in Taiwan for more than 18 months, having determined in late 2015 that the region's focus on functional inks and pastes could provide an important route to market for Haydale's tailored graphene-based materials. The work involved market assessments, in-country technical capability, ability to gain regulatory approvals and gaining a deep understanding of the targeted print customers' needs.

 

Haydale's proprietary graphene-based pastes have been developed in the Far East focussed on the Self-Monitoring Blood Glucose ('SMBG') device market. To date Haydale's inks have been incorporated into test products with several Taiwan-based printing customers who have been progressing regulatory approval for sales of their diagnostic products incorporating Haydale inks into the US and EU markets. Although Haydale has no current visibility on order quantities, the Group anticipates that sales of its tailored graphene-based paste to these customers will commence during the 2017 calendar year.

 

Traditionally, highly conductive inks and pastes have been dominated by metal-based inks incorporating silver and copper. Whilst graphene is not expected to completely replace the conductive properties of silver-based inks, provided it meets acceptable printer specifications, graphene offers many advantages such as recyclability, lower unit costs and the fact that the material is not susceptible to volatile market price movements.

A key reason for Haydale targeting the SMBG sector opportunity is that, according to market research firm Research & Markets, the SMBG device market is expected to grow to over US$16 billion by 2020 as the incidence of diabetes is increasing dramatically, with more than 640 million sufferers estimated worldwide by 20401.

 

Commenting on the opening of HTW, Ray Gibbs, CEO of Haydale, said:

"The development of our graphene-based inks has been focused on the screen printing market for over three years, which started with Haydale being awarded an Innovate UK grant for the production of ink for the self-monitoring blood glucose device market. Three years later we have expectations on securing sales this calendar year and the necessary FDA and regulatory approvals through dedicated printers such that we were confident to open a operation facility in Taiwan to service our collaboration partners' needs. The biomedical sensor market is massive and we consider that the Far East has a significant portion of this growing sector. I look forward to making more announcements on progress in ink sales over the coming months."

 

 

1. (Source:https://www.researchandmarkets.com/research/vhwlsj/blood_glucose).

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

 

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Trevor Phillips, Head of Communications

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

 

Tony Rawlinson / Emma Earl

Tel: +44 (0) 20 7213 0880

 

 

 

Cantor Fitzgerald Europe (Broker)

 

David Foreman / Will Goode (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Mark Westcott / Alex Pollen (Sales)

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and advanced materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Japan, Australia and China and operates from six facilities in the UK, USA and the Far East.

 

For more information please visit: www.haydale.com

Twitter: @haydalegraphene

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGGRKRVGNZM
Date   Source Headline
23rd Dec 20167:00 amRNSIssue of Shares
15th Dec 20163:00 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
28th Nov 20167:00 amRNSAgreement with Huntsman Advanced Materials
22nd Nov 20167:00 amRNSAnnual Financial Report
19th Oct 20167:00 amRNSPDMR Dealings
18th Oct 20167:00 amRNSPDMR Dealings
17th Oct 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSDistribution Agreement
13th Oct 20167:00 amRNSPDMR Dealings
11th Oct 20167:00 amRNSResult of Open Offer and Total Voting Rights
28th Sep 20167:00 amRNSContract Extension
23rd Sep 201610:57 amRNSResult of Placing
23rd Sep 20167:01 amRNSFinal Results
23rd Sep 20167:00 amRNSProposed Acquisition and Fundraise
9th Sep 20164:05 pmRNSCompletion of Innophene Acquisition
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
25th Aug 20167:00 amRNSAcquisition and Issue of Equity
11th Aug 20167:00 amRNSGraphene Enhanced PLA Filaments for 3D Printing
8th Aug 20167:00 amRNSHaydale Funds New Professorial Chair Within WCPC
29th Jul 20167:00 amRNSBoard Change
7th Jun 201610:42 amRNSGrant of Warrants
26th May 20167:00 amRNSAgreement with Flowtite Technology AS
20th May 20163:27 pmRNSDirector Dealing
20th May 20167:00 amRNSGrant of Options
18th May 20167:00 amRNSReactor Supply and Collaboration Agreement
9th May 20167:00 amRNSInvestor Open Day
25th Apr 20164:40 pmRNSHolding(s) in Company
7th Apr 201611:28 amRNSCorrection: Joint Development & Supply Agreement
7th Apr 20167:00 amRNSJoint Development and Supply Agreement
22nd Mar 20167:00 amRNSHalf Yearly Report
14th Mar 20167:00 amRNSGraphene Enhanced Composite Products Launched
8th Mar 201611:12 amRNSNotice of Results
16th Feb 20167:00 amRNSGrant Awards
4th Feb 20167:00 amRNSHaydale Commission Composite Pipe Testing Facility
3rd Feb 20167:00 amRNSAcquisition of Rights and Grant of Warrants
3rd Dec 201511:58 amRNSResult of AGM
1st Dec 201512:05 pmRNSDirector Dealing
26th Nov 20157:00 amRNSHolding(s) in Company
25th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 201510:50 amRNSResults of General Meeting
20th Nov 20151:14 pmRNSResult of Open Offer
17th Nov 20157:00 amRNSGrant Awards
10th Nov 201511:32 amRNSNotice of AGM
6th Nov 20154:45 pmRNSPosting of Open Offer Application Forms
2nd Nov 201512:50 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:01 amRNSIssue of Equity
2nd Nov 20157:00 amRNSFinal Results
14th Oct 20157:00 amRNSEuropean Patent Grant
1st Oct 20157:00 amRNSAgreement with Scott Bader Company Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.